Trial intelligence / Profile preview

Preoperative Valdecoxib CNS Penetration and Effects

NCT00122096Phase 4Completed

Sponsor
University of Washington
Start
Nov 2002
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative pain comparing Valdecoxib with Placebo (2 arms). Primary endpoint: Cerebrospinal fluid valdecoxib concentration. Started Nov 2002; status: completed.

02

Drugs

valdecoxib
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00122096.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00122096.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call